The etiology of schizophrenia is unclear, although family, twin, and linkage studies implicate genetic factors. Here, we identified adenomatous polyposis coli (APC), a tumor suppressor gene, as a risk factor for schizophrenia. We compared leukocytic gene expression patterns of six pairs of patients with schizophrenia and healthy controls by microarray. APC expression levels were significantly increased in all patients compared to healthy controls. To confirm the findings of microarray analysis, we measured expression levels of APC in the leukocytes from 30 relapse patients taking antipsychotic medication, 29 first-episode drug-naïve patients, and 30 healthy controls using real-time quantitative reverse transcription (RT)-polymerase chain reaction (PCR). APC expression levels were significantly increased in leukocytes of schizophrenics both taking and not taking antipsychotic medication and hence the increase of APC expression was not due to antipsychotic medication. APC is located at 5q21-22, which has been previously reported to be linked with schizophrenia. Further, we performed the transmission disequilibrium test (TDT) and TDT based on haplotypes to search for the association between schizophrenia and APC by examining 163 parent-offspring trios of Chinese descent. We analyzed three single-nucleotide polymorphisms (SNPs) (rs2229992, rs42427, rs465899) at the exon region of APC. TDT showed that the three SNPs are significantly associated with schizophrenia (TDT v 2 ¼ 4.23, Po0.05; 4.15, Po0.05; 8.49 Po0.01, respectively; HHRRv 2 ¼ 5.54, Po0.05; 4.40, Po0.05; 9.79, Po0.01, respectively). We found a significant association between the APC haplotypes from rs2229992-rs42427-rs465899 and schizophrenia (Global v 2 ¼ 44.376,df ¼ 7, Po0.001). The C-A-T haplotype has a frequency of more than 57% and has a strong association with schizophrenia (v 2 ¼ 15.04, Po0.001). These results indicate that the APC may be a candidate gene conferring susceptibility to schizophrenia and also may be associated with reduced vulnerability to cancer in schizophrenia.
Schizophrenia is a severe and common neuropsychiatric disorder that affects about 1% of the population. Although the pathogenesis of this complex illness has not been unraveled, it is generally accepted that genetic factors play an important role in the pathogenesis of schizophrenia. However, the identification of specific genes that are associated with schizophrenia has proven to be difficult. A reduced incidence of cancer was observed in schizophrenic patients compared with the general population. 1, 2 The relationship between schizophrenia and cancer has posed an epidemiological puzzle for decades. Particular attention has been paid to the question whether genetic predisposition toward schizophrenia confers genetically reduced susceptibility to cancer. The reduced incidence of cancer observed in schizophrenic patients may be related to differences in genetic background. Catts and Catts 1 proposed a hypothesis that increased apoptosis might account for neurodevelopmental abnormalities as well as tumor resistance associated with schizophrenia. However, little is known about whether patients with schizophrenia possess genetic factors that also confer tumor resistance. Park et al 3 found a genetic association between schizophrenia and lung cancer by analyzing polymorphic sites in the p53 gene. To detect causative genes, we used DNA microarray analysis using leukocytes from the patients with schizophrenia and healthy controls. We found differential expression pattern between schizophrenic patients and controls. Among the altered regulated genes, we focused on APC (adenomatous polyposis coli), a tumor suppressor associated with both familial and sporadic colon cancer, which is upregulated in all schizophrenic patients.
APC is mutated in familial adenomatous polyposis and in sporadic colorectal tumors. 4, 5 It is one of the most frequently mutated genes and is downregulated in many types of cancer. 6, 7 APC is also a key component of the Wnt/Wingless signaling transduction pathway that plays important roles in a number of developmental processes and in tumorigenesis. 8 Wnt/Wingless signaling plays important roles in neural development. 9 Recently, evidences for potential disturbances of Wnt signaling pathways in schizophrenia have accumulated. [10] [11] [12] [13] [14] [15] However, as far as the authors are aware, the involvement of APC in schizophrenia has not been reported. The immunoprecipitation experiment results suggested that APC is involved in cell adhesion. 16, 17 Several researches have reported that abnormalities of neural cell adhesion exist in schizophrenia. 18, 19 APC colocalized with DLG (DLG, the human homolog of the Drosophila discs large tumor suppressor protein) at the lateral cytoplasm in rat colon epithelial cells and at the synapse in cultured hippocampal neurons. The APC-DLG complex participates in the regulation of both cell cycle progression and neuronal function. 20 Kawasaki et al 21 suggested that the APC-ASEF complex (ASEF, a Rac-specific guanine nucleotide exchange factor) regulates the actin cytoskeletal network, cell morphology and migration, and neuronal function. Recently, it has been reported that the mouse tumor suppressor protein APC has a role in acetylcholine receptor clustering and that the Wnt/bcatenin pathway crosstalks with agrin signaling cascade during synapse formation. 22 Hippocampal formation, 23, 24 synapse formation, 25 and dysfunction of a prefrontal-hippocampal network 26 are believed to be closely involved in the pathophysiology of schizophrenia. Thus, there might be relationship between the functions of APC and the neural mechanisms underlying schizophrenia.
APC, consisting of 17 exons, is widely expressed in the brain as well as in other tissues. Interestingly, APC is located at 5q21-22, which has been previously reported to be linked with schizophrenia. 27, 28 In their genome scan for schizophrenia genes in Irish pedigrees, D5S393, D5S804, and D5S818 showed strong evidence for linkage with schizophrenia. They suggest that region 5q21-31 is likely to contain genes that influence liability to schizophrenia.
Thus, APC is likely to be a candidate gene for schizophrenia in terms of its physical location and function. To further investigate the role of APC in schizophrenia susceptibility, in the present work, we examined the expression of APC by microarray and real-time quantitative reverse transcription (RT)-polymerase chain reaction (PCR). We also adopted the transmission disequilibrium test (TDT), haplotypebased haplotype relative risk (HHRR), and haplotype TDT methods to analyze the presence of linkage disequilibrium between APC and schizophrenia.
Materials and methods

Subject
For the DNA microarray analysis, we enrolled six Chinese schizophrenic patients (mean age was 3575 years (mean7SD); course was 1477 years (mean7SD); scores of PANSS X90; at least one of the first-degree relatives has schizophrenia) and six healthy controls (mean age was 3374 years). The demographics of patients (n ¼ 6) and healthy controls (n ¼ 6) that were analyzed for the DNA microarray analysis are shown in Table 1 All patients with schizophrenia met DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4th edition, American Psychiatry Association, 1994) criteria as determined by the Structured Clinical Interview for DSM-IV (SCID). The healthy control subjects were screened using the SCID for DSM-IV or an unstructured interview to exclude major Axis I disorders, including substance dependence, psychotic disorders (including schizophrenia or schizophrenia-like disorders), mood disorders, and anxiety disorders. The severe physical diseases (eg hypertension, diabetes, and cancer) also were excluded by medical examination. The healthy control subjects also had no family history of mental disorder. This study was approved by the Ethics Committee of Shanghai Mental Health Center. All subjects, both cases and controls, signed informed consent.
DNA microarray analysis
We carried out DNA microarray analysis using HS8000 microarray (containing 8000 genes) according to the protocols of the manufacturer (Shanghai United Gene company, China). Total RNA was extracted, respectively, from 100 ml of each subject's peripheral blood using TRIzoL (GIBCO, USA). Each of the schizophrenic samples was compared with a pooled control RNA on each of the microarrays. For each sample pair, patients' RNA was labeled with a fluorescent dye Cy5 and controls' RNA was labeled with fluorescent dye Cy3 during RT(Superscript II) and then mixed to use as probes for hybridization on the same microarray. The fluorescent signals were scanned (GenePix4000B scanner AXON) and data analysis was performed using software GenePix Pro3.0 29 Differentially expressed genes compared with the controls were defined based on the following criteria: 1.5-fold or greater change in the expression level of each patient-control pair (eg the cy5/cy3 signal intensity ratio was greater than 1.500 as upregulated expression and smaller than 0.667 as downregulated expression).
Real-time quantitative RT-PCR
Total RNA from 89 peripheral blood samples (59 patients with schizophrenia or schizophrenia-like disorders and 30 healthy controls) was extracted with the QIAamp RNA blood Mini Kit (Qiagen, Chatsworth, CA, USA) and treated with DNase (Qiagen, Chatsworth CA, USA) in tubes. cDNA was synthesized by using Omniscript Reverse Transcription Reagents (Qiagen, Chatsworth, CA, USA) with a random primer. APC mRNA expression levels were measured by real-time quantitative RT-PCR, which use TaqMan MGB Probes Recommended and an ABI Prism 7900 sequence detection system with 384-well format according to the manufacturer's protocol. Specific primer and TaqMan MGB probe of APC (Assay-on-demand) (Applied Biosystems, Foster city, CA, USA) and TaqMan Universal PCR Mastermix used for real-time PCR were purchased from Applied Biosystems, Branchburg city, CA, USA. Real-time quantitative PCR reaction was carried out according to TaqMan Universal PCR Mastermix protocol. For the RNA internal control, we derived C t using GAPDH mRNA expression. The GAPDH RNA assay kit was purchased from Applied Biosystems, Foster city, CA, USA. The PCR reaction and protocol for the GAPDH were the same as described above. Experiments were performed with duplicates for each sample. Results of the real-time PCR data were represented as C t values, where C t was defined as the threshold cycle of PCR at which the amplified product was first detected. We used a comparative C t Method. The DC t -value of each sample (patients and controls) was obtained by subtracting the average GAPDH C t -value of each sample from the average APC C t -value of each sample. The differences of expression level of APC between schizophrenics and controls were compared using ttest (two-tailed) and ANOVA (one-way). Then, we used the average DC t of 30 control subjects as the calibrator. The fold change was calculated according to the formula 2 ÀDDC t , where DDC t was DC t of individual patients minus the DC t of calibrator value, respectively. 30 Linkage disequilibrium analysis Single-nucleotide polymorphisms (SNPs) selection There are totally 254 SNPs in the APC gene region. (http:// www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?locusId ¼ 324 &chooseRs ¼ all). We selected SNPs according to the following principles: (1) Heterozygosity of SNPs should be more than 0.30 for feasibility of TDT analyses. Of the 254 SNPs, 44 met the criteria. (2) The polymorphic site represented a recognition site for restriction enzyme (finding recognition site by using software Primer 5 Program) for feasibility of genotyping by PCR-RFLP. Of 44 SNPs, 20 met the criteria. (3) We finally selected three SNPs randomly for TDT analysis from among those 20 SNPs. These three SNP markers (name, contig position, and polymorphic site are given in Table 2 ) span a chromosomal interval of 14.3 kb between exon 13 and exon 17 in the APC (Figure 1 ).
Genetyping Genomic DNA was extracted from peripheral blood of 163 parent-offspring trios of Chinese, consisting of the schizophrenic individuals and their biological parents by standard methods. PCR was used to amplify the fragment of genomic DNA containing the rs2229992(C/T), rs42427(A/G), and rs465899(C/T) of APC ( Figure 1 ).We used the following primers designed by primer 5 program (Table 2 ). We performed PCR in a final volume of 30 ml containing 1.5 mmol/l MgCl 2 , 50 mmol/l KCl, 10 mmol/l Tris HCl pH 8.4, 1 U of Taq polymerase, 100 mg/ml gelatin, 0.2 mM dNTPs, 12 pmol primers, and 100-200 ng DNA. The PCR conditions were as follows: after an initial denaturation at 951C for 3 min; 32 cycles at 951C for 30 s, different annealing temperature (Table 2) for 30 s, and at 721C for 30 s were performed, followed by an extension at 721C for 7 min. The PCR products were digested by restriction enzymes AfaI, BsiHkAI, and MspI for rs2229992 (C/ T), rs42427(A/G), and rs465899(C/T), respectively. The digested products were subjected to electrophoresis on a 2% agarose gel. Gels were stained with ethidium bromide, and the bands were visualized under ultraviolet light. The DNA bands were assigned allele numbers based on their size: (1) 
Statistical analysis
In this study, the association analysis was performed with 163 nuclear family trios and three strategies were used, the HHRR, 31 TDT, 32 and multiple marker haplotypes TDT. 33 We used HHRR and TDT to avoid any potential population stratification. In these methods, the nontransmitted parental alleles were used as 'controls' to evaluate allele transmission. TDT uses data from heterozygous parents only, and tests for individual markers. Furthermore, multiple marker haplotypes transmission was performed with the program TRANSMIT v2.5. The program TRANSMIT tests for association between markers and disease, examining the transmission of multilocus haplotypes. The genotype and allele frequencies of offspring and parents were calculated and the distribution of genotype frequencies for Hardy-Weinberg equilibrium (H-WE) was tested using w 2 .
Results
Microarray gene expression
To detect candidate gene effectively, we used DNA microarray analyses using peripheral blood leukocytes from six schizophrenics and six healthy controls. There were 31 genes that met the criteria for differential expression in all schizophrenic patients as compared with controls. Among the genes, 29 genes were downregulated and two genes were upregulated (data not shown here). We focused on APC, which was upregulated in all schizophrenic patients in the present work (Table 3) .
Real-time quantitative RT-PCR
To further confirm the microarray results and exclude the effect of antipsychotics on the gene expression levels, we conducted real-time quantitative RT-PCR using 30 relapse patients with schizophrenia who used antipsychotic medication, 29 first-episode patients with schizophrenia who never used antipsychotic medication, and 30 healthy controls. The realtime PCR showed that APC expression levels, normalized by GAPDH, were significantly increased in total schizophrenic patient group (p ¼ 0.001) compared with healthy control subjects (Table 4) . Then, the patient group was divided into two subgroups: 30 relapse patients who used antipsychotic medication and 29 first-episode patients who never used antipsychotic medication. Compared with healthy control group, APC expression levels, normalized by GAPDH, were significantly increased, respectively, in nonantipsychotic medication-using subgroup SNPs, single-nucleotide polymorphisms; APC, adenomatous polyposis coli.
Figure 1 The sites of SNPs in APC.
APC association with susceptibility to schizophrenia DH Cui et al (P ¼ 0.013) and antipsychotic medication-using subgroup (P ¼ 0.018). There were no significant differences in expression levels between the two patient groups (P ¼ 0.883) ( Table 5 ). Taking average DC t of healthy control as calibrator, we calculated 2 ÀDDC t of every individual patient. On comparing with healthy control, we found that the average expression level of APC of patients is higher by about 30% (Figure 2 ).
Linkage disequilibrium analysis
Allele and genotype frequencies of offspring and parents are listed in We performed a TDT analysis by using haplotypes from rs2229992, re42427, and rs465899 polymorphisms of APC (Table 8) . We found a significant association between the APC haplotypes, rs2229992-rs42427-rs465899, and schizophrenia (Global w 2 ¼ 44.376, df ¼ 7, Po0.001). In our results, there are five common individual haplotypes of APC whose frequencies are more than 3%. Three (T-G-T, C-A-T, C-A-C) of them were significantly associated with schizophrenia. One of them is C-A-T, which has a frequency of 57% and has the strongest association with schizophrenia (w 2 ¼ 15.04, Po0.001). T-test of APC expression levels normalized by GAPDH. Significant differences are denoted in bold. Significant differences are denoted in bold. F, first-episode schizophrenic patients who never used antipsychotic medication; R, relapse patients who used antipsychotic medication; C, normal controls. Figure 2 Relative expressions of APC in schizophrenic patients. F, first-episode schizophrenic patients who never used antipsychotic medication; R, relapse patient who used antipsychotic medication; F þ R, total patients. Each dot represents the expression level of an individual patient. APC expression level of each patient is normalized by dividing the mean of the value of control subjects (n ¼ 30), which is indicated by the dotted line in the plot. Compared with the normal control group, APC expression levels are increased in F þ R, F, and R by 30.73, 31.58, and 29.91%, respectively (indicated by short bars).
Discussion
To detect candidate genes effectively, we compared peripheral leukocyte gene expression patterns of six pairs of patients and healthy controls by microarray consisting of 8000 human genes. We found that 31 genes differently expressed in schizophrenia. Among them, we focused on APC, whose expression levels were significantly increased in all patients with schizophrenia compared with healthy controls. 
1 is the allele that cannot be recognized by restriction enzymes, and 2 is the allele that can be recognized by restriction enzymes. Table 7 TDT and HHRR analyses for the APC polymorphisms in 163 Chinese schizophrenic trios
Number of transmissions To confirm the finding of DNA microarray analysis, and to attempt to control for effect of drug treatment on gene expression, we measured mRNA expression levels of APC in the leukocytes from 30 relapse patients who used antipsychotic medication, 29 firstepisode patients who did not use antipsychotic medication, and 30 healthy controls using real-time quantitative RT-PCR. Our data showed that the expression levels of APC were significantly increased in peripheral leukocytes of antipsychotic medicationusing and -nonusing schizophrenics compared with healthy controls. The results suggest that the change of expression was not due to the effect of antipsychotic medication.
A benefit of microarray studies is parallel examination of thousands of molecular markers, which might be helpful in pinpointing pathophysiological pathways in schizophrenia. However, metabolism and regulatory processes of viable tissue of subjects with central nervous system (CNS) disorders are difficult to assess. Systematic biochemical investigations with brain biopsies of psychiatric patients are unrealistic. Primarily microarray studies of neuropsychiatric disorders to date have been limited to studies of brain tissue from postmortem samples. Peripheral microarray studies of living subjects may be useful especially if the brain-related changes are reflected in the lymphocyte. Recently, it was proposed that peripheral lymphocytes could reflect the metabolism of brain cells. 34 Vawter et al 35 have reported microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Gladkevich et al provide arguments to consider blood lymphocytes as a convenient neural probe of-an albeit -limited number of cellular functions, including gene expression. Their arguments are based on three features: (1) altered lymphocyte functions in neuropsychiatric disorders, (2) the expression of neuroactive proteins and processes in lymphocytes, and (3) reported similarities of hormonal effects on the nervous system processes and lymphocyte physiology. The bidirectional communication between the immune-in lymphocytes, particularly-and nervous systems occur through a complex network involving the nervous, endocrine, and immune systems. Hormones, cytokines, and neurotransmitters are the main communicators between the nervous and immune systems. There may also be trait-or staterelated changes that could be useful in subtyping schizophrenia based upon cellular responses to stress and medications that can be observed in microarray analysis of leukocytes. Therefore, lymphocytes may be a convenient and accessible alternative for studies of psychiatric disorders. 34, 35 Another goal of microarray studies of gene expression is to help prioritize mutation and SNP searches in linkage hot spots. This could be important since linkage regions of complex disorders such as schizophrenia are typically rather large (10-30 Mb as a rule) and can contain hundreds of brain-related genes. 36 Microarray studies of gene expression will be helpful to find candidate genes within these broader linkage regions through a combination of microarray and traditional linkage studies.
The APC is located at 5q21-22, which has been previously reported to be linked with schizophrenia. 27, 28 We performed TDT, HHRR, and TDT based on haplotypes to search for the association between schizophrenia and APC. We examined 163 Chinese family trios for testing possible preferential transmission of the rs2229992, rs42427, and rs465899 alleles from parents to their affected offspring. We found a significant transmission distortion of the three SNPs from parents to offspring (TDT Linkage disequilibrium mapping is a promising method for identifying susceptibility alleles for complex genetic diseases such as schizophrenia. To avoid confounding effects of population stratification inherent in case-control study design, family-based tests of association were developed. The TDT analysis uses only heterozygous parental genotypes and HHRR uses all parental genotypes. Compared with the case-control design, TDT has a number of advantages: it tests for linkage and linkage disequilibrium simultaneously; it is not prone to false positives due to population stratification; and it uses model-free methods of analysis. Clayton and John 33 developed a haplotyte TDT to compare transmitted and untransmitted haplotypes. It is a widely held opinion that haplotyping may be the most sensitive method of detecting association. 37 There are three obvious explanations for our TDT findings, that of true association of APC with schizophrenia in the Han Chinese, that of linkage reflecting a susceptibility gene within or close to the APC region, or finally a chance association, since no other studies have reported association of transmission distortion with this gene. In fact, to our knowledge, there are few studies that have reported involvement of APC in schizophrenia.
Is there evidence for a direct involvement of APC in schizophrenia? APC has strong credentials as a functional, positional, and differentially expressed candidate gene for schizophrenia. First, APC is a tumor suppressor, which is mutated in many tumors 6, 7 as well as in familial adenomatous polyposis and in sporadic colorectal tumors. 4, 5 It is downregulated in many types of cancer 6, 7 and is upregulated in schizophrenia shown in the present study. Epidemiological findings showed reduced incidence of cancer observed in schizophrenic patients compared with the general population. 1, 2 APC may confer susceptibility to schizophrenia and also be associated with reduced vulnerability to cancer in schizophrenia. Second, APC is a key component of the Wnt/Wingless signaling transduction pathway, which plays important roles in a number of developmental processes and in tumorigenesis. 8 Moreover, APC is widely expressed in the brain as well as other tissues, and is involved in cell adhesion and neuronal function. 17, 20 Several researches have reported that abnormalities of neural cell adhesion, neuronal function, and Wnt/Wingless exist in schizophrenia. [10] [11] [12] [13] [14] [15] 18, 19, [23] [24] [25] [26] Third, APC is located at 5q21-22, which has been previously reported to be linked with schizophrenia. 27, 28 Three SNPs of APC are associated with schizophrenia.
In conclusion, our results and other studies indicated that dysregulation of the Wnt/wingless signaling pathway may be involved in the predisposition to schizophrenia. Considering that schizophrenia is not a single-gene disease, APC might be one of the susceptibility genes for schizophrenia. Our findings may need to be confirmed by replication in other populations or methods. The role of APC in the etiology of schizophrenia is not clear and awaits further investigation.
